BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 22340268)

  • 1. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.
    Singelyn JM; Sundaramurthy P; Johnson TD; Schup-Magoffin PJ; Hu DP; Faulk DM; Wang J; Mayle KM; Bartels K; Salvatore M; Kinsey AM; Demaria AN; Dib N; Christman KL
    J Am Coll Cardiol; 2012 Feb; 59(8):751-63. PubMed ID: 22340268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
    J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.
    Dorsey SM; McGarvey JR; Wang H; Nikou A; Arama L; Koomalsingh KJ; Kondo N; Gorman JH; Pilla JJ; Gorman RC; Wenk JF; Burdick JA
    Biomaterials; 2015 Nov; 69():65-75. PubMed ID: 26280951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable OPF/graphene oxide hydrogels provide mechanical support and enhance cell electrical signaling after implantation into myocardial infarct.
    Zhou J; Yang X; Liu W; Wang C; Shen Y; Zhang F; Zhu H; Sun H; Chen J; Lam J; Mikos AG; Wang C
    Theranostics; 2018; 8(12):3317-3330. PubMed ID: 29930732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.
    Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL
    Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model.
    Zhang Y; Zhu D; Wei Y; Wu Y; Cui W; Liuqin L; Fan G; Yang Q; Wang Z; Xu Z; Kong D; Zeng L; Zhao Q
    Acta Biomater; 2019 Mar; 86():223-234. PubMed ID: 30660010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widely distributable and retainable in-situ gelling material for treating myocardial infarction.
    Le HT; Mahara A; Fukazawa K; Nagasaki T; Yamaoka T
    Acta Biomater; 2024 Mar; 176():221-233. PubMed ID: 38242190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.
    Yoshizumi T; Zhu Y; Jiang H; D'Amore A; Sakaguchi H; Tchao J; Tobita K; Wagner WR
    Biomaterials; 2016 Mar; 83():182-93. PubMed ID: 26774561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.
    Seif-Naraghi SB; Singelyn JM; Salvatore MA; Osborn KG; Wang JJ; Sampat U; Kwan OL; Strachan GM; Wong J; Schup-Magoffin PJ; Braden RL; Bartels K; DeQuach JA; Preul M; Kinsey AM; DeMaria AN; Dib N; Christman KL
    Sci Transl Med; 2013 Feb; 5(173):173ra25. PubMed ID: 23427245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An injectable silk sericin hydrogel promotes cardiac functional recovery after ischemic myocardial infarction.
    Song Y; Zhang C; Zhang J; Sun N; Huang K; Li H; Wang Z; Huang K; Wang L
    Acta Biomater; 2016 Sep; 41():210-23. PubMed ID: 27262742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Assessment of Decellularized Porcine Myocardial Slice as an Acellular Cardiac Patch.
    Shah M; Kc P; Zhang G
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23893-23900. PubMed ID: 31188555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel.
    Yoon SJ; Fang YH; Lim CH; Kim BS; Son HS; Park Y; Sun K
    J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):163-71. PubMed ID: 19399850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
    Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Decellularized Extracellular Matrix Hydrogel Containing Stromal Cell-Derived Factor 1 Promotes Transplanted Cardiomyocyte Engraftment and Functional Regeneration after Myocardial Infarction.
    Wu K; Wang Y; Yang H; Chen Y; Lu K; Wu Y; Liu C; Zhang H; Meng H; Yu Q; Zhang Y; Shen Z
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2578-2589. PubMed ID: 36598791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling.
    Rodell CB; Lee ME; Wang H; Takebayashi S; Takayama T; Kawamura T; Arkles JS; Dusaj NN; Dorsey SM; Witschey WR; Pilla JJ; Gorman JH; Wenk JF; Burdick JA; Gorman RC
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27729419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placenta hydrogel reduces scarring in a rat model of cardiac ischemia and enhances cardiomyocyte and stem cell cultures.
    Francis MP; Breathwaite E; Bulysheva AA; Varghese F; Rodriguez RU; Dutta S; Semenov I; Ogle R; Huber A; Tichy AM; Chen S; Zemlin C
    Acta Biomater; 2017 Apr; 52():92-104. PubMed ID: 27965171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction.
    Rane AA; Chuang JS; Shah A; Hu DP; Dalton ND; Gu Y; Peterson KL; Omens JH; Christman KL
    PLoS One; 2011; 6(6):e21571. PubMed ID: 21731777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.
    Sharp TE; Schena GJ; Hobby AR; Starosta T; Berretta RM; Wallner M; Borghetti G; Gross P; Yu D; Johnson J; Feldsott E; Trappanese DM; Toib A; Rabinowitz JE; George JC; Kubo H; Mohsin S; Houser SR
    Circ Res; 2017 Nov; 121(11):1263-1278. PubMed ID: 28912121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration.
    Qi Q; Zhu Y; Liu G; Yuan Z; Li H; Zhao Q
    Biomed Pharmacother; 2020 Sep; 129():110382. PubMed ID: 32590191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.